EU/US Properties Organoleptics Cosmetics Suppliers Safety Safety in use Safety references References Other Blenders Uses Occurrence Synonyms Articles Notes
 

chlorzoxazone
5-chloro-2-hydroxybenzoxazole

Supplier Sponsors

Name:5-chloro-3H-1,3-benzoxazol-2-one
CAS Number: 95-25-0Picture of molecule3D/inchi
Other(deleted CASRN):32850-84-3
ECHA EINECS - REACH Pre-Reg:202-403-9
FDA UNII: H0DE420U8G
Nikkaji Web:J3.950K
MDL:MFCD00005717
XlogP3:1.80 (est)
Molecular Weight:169.56628000
Formula:C7 H4 Cl N O2
BioActivity Summary:listing
NMR Predictor:Predict (works with chrome, Edge or firefox)
Category:pharmaceuticals / chemical synthisis
 
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Google Scholar:Search
Google Books:Search
Google Scholar: with word "volatile"Search
Google Scholar: with word "flavor"Search
Google Scholar: with word "odor"Search
Google Patents:Search
US Patents:Search
EU Patents:Search
Pubchem Patents:Search
PubMed:Search
NCBI:Search
 
Physical Properties:
Assay: 95.00 to 100.00
Food Chemicals Codex Listed: No
Melting Point: 191.50 °C. @ 760.00 mm Hg
Boiling Point: 336.90 °C. @ 760.00 mm Hg (est)
Vapor Pressure:0.000056 mmHg @ 25.00 °C. (est)
Flash Point: 316.00 °F. TCC ( 157.50 °C. ) (est)
logP (o/w): 1.816 (est)
Soluble in:
 water, 2709 mg/L @ 25 °C (est)
 
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found).
 
Cosmetic Information:
None found
 
Suppliers:
BOC Sciences
For experimental / research use only.
Chlorzoxazone >98%
Odor: characteristic
Use: Chlorzoxazone is a muscle-relaxing drug, and a probe for human liver cytochrome P-450IIE1.
Glentham Life Sciences
Chlorzoxazone
Sigma-Aldrich: Sigma
For experimental / research use only.
Chlorzoxazone
TCI AMERICA
For experimental / research use only.
Chlorzoxazone >98.0%(GC)(T)
 
Safety Information:
Preferred SDS: View
 
Hazards identification
 
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
 
Pictogram
 
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
intraperitoneal-hamster LD50 166 mg/kg
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960.

oral-hamster LD50 662 mg/kg
BEHAVIORAL: ATAXIA BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960.

intraperitoneal-mammal (species unspecified) LD50 550 mg/kg
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Chimica Therapeutica. Vol. 6, Pg. 65, 1971.

oral-man TDLo 50 mg/kg
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: COMA
American Journal of Emergency Medicine. Vol. 16, Pg. 393, 1998.

intraperitoneal-mouse LD50 50 mg/kg
National Technical Information Service. Vol. AD277-689

oral-mouse LD50 440 mg/kg
Arzneimittel-Forschung. Drug Research. Vol. 17, Pg. 242, 1967.

intraperitoneal-rat LD50 150 mg/kg
BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ATAXIA
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960.

oral-rat LD50 763 mg/kg
BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ATAXIA
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960.

Dermal Toxicity:
subcutaneous-mouse LD50 170 mg/kg
BEHAVIORAL: ANTICONVULSANT
Acta Pharmacologica et Toxicologica. Vol. 19, Pg. 247, 1962.

Inhalation Toxicity:
Not determined
 
Safety in Use Information:
Category:
pharmaceuticals / chemical synthisis
Recommendation for chlorzoxazone usage levels up to:
 not for fragrance use.
 
Recommendation for chlorzoxazone flavor usage levels up to:
 not for flavor use.
 
Safety References:
EPI System: View
ClinicalTrials.gov:search
Daily Med:search
AIDS Citations:Search
Cancer Citations:Search
Toxicology Citations:Search
EPA Substance Registry Services (TSCA):95-25-0
EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
Laboratory Chemical Safety Summary :2733
National Institute of Allergy and Infectious Diseases:Data
WGK Germany:3
5-chloro-3H-1,3-benzoxazol-2-one
Chemidplus:0000095250
RTECS:DM5250000 for cas# 95-25-0
 
References:
 5-chloro-3H-1,3-benzoxazol-2-one
NIST Chemistry WebBook:Search Inchi
Canada Domestic Sub. List:95-25-0
Pubchem (cid):2733
Pubchem (sid):134971727
 
Other Information:
(IUPAC):Atomic Weights of the Elements 2011 (pdf)
Videos:The Periodic Table of Videos
tgsc:Atomic Weights use for this web site
(IUPAC):Periodic Table of the Elements
CHEBI:View
CHEMBL:View
KEGG (GenomeNet):C07931
HMDB (The Human Metabolome Database):HMDB14500
Export Tariff Code:2934.99.4400
MedlinePlusSupp:View
ChemSpider:View
Wikipedia:View
 
Potential Blenders and core components note
None Found
 
Potential Uses:
None Found
 
Occurrence (nature, food, other):note
 not found in nature
 
Synonyms:
2-benzoxazolinone, 5-chloro-
2-benzoxazolol, 5-chloro-
2(3H)-benzoxazolone, 5-chloro-
5-chlorbenzoxazolin-2-one
5-chloro-1,3-benzoxazol-2(3H)-one
5-chloro-2-benzoxazolinone
5-chloro-2-hydroxybenzoxazole
5-chloro-2,3-dihydro-2-oxo-1,3-benzoxazole
5-chloro-2(3H)-benzoxazolone
5-chloro-3-hydrobenzoxazol-2-one
5-chloro-3(H)-2-benzoxazolone
5-chloro-3H-1,3-benzoxazol-2-one
5-chloro-3H-benzooxazol-2-one
5-chloro-3H-benzoxazol-2-one
5-chloro-benzooxazol-2-ol
5-chlorobenzoxazol-2-one
5-chlorobenzoxazolidone
5-chlorobenzoxazolin-2-one
 chloroxazone
 chlorsoxazone
 chlorzoxane
 chlorzoxazon
2-hydroxy-5-chlorobenzoxazole
 myoflexin
 myoflexine
 neoflex
 paraflex
 parafon
 pathorysin
 relaxazone
 solaxin
 
 
Notes:
a centrally acting central muscle relaxant with sedative properties. it is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (from martindale, the extra pharmacopoea, 30th ed, p1202)
Please share your Comments.
Email Address:
Top of Page Home
Copyright © 1980-2021 The Good Scents Company (tgsc) ™ Disclaimer Privacy Policy